Zevra Therapeutics develops and commercializes therapeutics for rare diseases.
3 recorded benefits. Record edited: Thu Sep 17 2026 09:45:14 GMT+0000 (Coordinated Universal Time).
Recorded work model: Varies by role; the current board lists Boston office roles and remote U.S. regional Medical Science Liaison roles..
The company has a 401(k) retirement plan covering substantially all employees
Read 2026-09-17T09:43:05.866Z
Published 2026-03-09T00:00:00.000Z
Current official annual filing for fiscal year ended December 31, 2025; current identity/status, headquarters, company size, rare-disease business, and employee retirement/profit-sharing plans.
The company may provide a discretionary match of up to 4% of participant compensation, vesting immediately; the match is discretionary and no other formula or eligibility term is stated
Read 2026-09-17T09:43:05.866Z
Published 2026-03-09T00:00:00.000Z
Current official annual filing for fiscal year ended December 31, 2025; current identity/status, headquarters, company size, rare-disease business, and employee retirement/profit-sharing plans.
A discretionary profit-sharing plan covers all employees and employees become eligible after three years of service; it records no contributions in 2025 or 2024, so no contribution amount is implied
Read 2026-09-17T09:43:05.866Z
Published 2026-03-09T00:00:00.000Z
Current official annual filing for fiscal year ended December 31, 2025; current identity/status, headquarters, company size, rare-disease business, and employee retirement/profit-sharing plans.